Project Grant K23DK147585
- Federal Project Grant Award Summary Colorado State University received a $119,536 Project Grant (R03) award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 6, 2026, with completion targeted for April 30, 2028. The award supports implementation science research that systematically identifies contextual determinants affecting the delivery of "What Can I...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver $756,480 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 5, 2025, for a project extending through June 30, 2030. This Project Grant supports research addressing critical evidence gaps in type 2 diabetes management by integrating real-world data from diverse patient populations with data from...
- Federal Grant Award Summary The University of Colorado-Denver received a $797,416 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2029. The award funds research investigating the immunogenetic mechanisms underlying Type 1 Diabetes (T1D) etiology and pathogenesis, with a focus on how genetic variability in natural...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $386,150 to the University of Colorado-Denver on February 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a mentored career development research project titled SMART-2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults with Type 2 Diabetes. The award, which extends through...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver $224,088 through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on June 11, 2025, with completion targeted for December 31, 2025. This mentored F32 postdoctoral fellowship supports research investigating the physiological regulation of energy intake at meals following weight loss, with Dr. Ezpeleta as...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $819,091 Project Grant on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on glucose patterns and clinical outcomes in the Dallas Heart Study. The research project, which extends through June 30, 2030, applies continuous glucose monitoring (CGM) systems and novel machine...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts University School of Medicine a Project Grant of $838,493 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research is being conducted in Dallas, Texas, with a completion date of February 28, 2031. The project, titled "Optimizing Interventions to Improve Nutrition Security and Reduce Diabetes Risk Among...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $248,965 Project Grant to the University of Colorado-Denver for research examining the relationship between pancreatic imaging traits and metabolic health in adolescents. Funded under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), this three-year award (March 1, 2026–February 28, 2029) supports Principal Investigator Dr. Catherine Cohen's K99/R00...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $188,632 to the University of Kansas Medical Center Research Institute, Inc. under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 1, 2025, through July 31, 2030. Dr. Daniel Tilden, MD, MPH, will lead the development and pilot testing of the Rural Emerging/Young Adult Collaborative Care for Type 1 Diabetes (REACT-T1D) program,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant of $248,975.00 to The Regents of the University of Colorado-Denver under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for research activities spanning from May 15, 2026, through April 30, 2029. The funded research investigates pancreatic beta-cell glucose toxicity and its relationship to messenger RNA (mRNA) translation, with...
Colorado State University received a $183,540 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through March 31, 2031. The award supports the development of a just-in-time adaptive intervention (JITAI) utilizing mobile health technology to promote physical activity in adolescents with type 2 diabetes. Under Aim 1, the project will identify time-varying factors influencing physical activity engagement through qualitative interviews with 18 stakeholders and a two-week ecological momentary assessment protocol with 25 adolescents with type 2 diabetes. Under Aim 2, the research team will co-develop intervention components, including personalized text messages and tailoring variables, with an advisory board of adolescents and caregivers drawing from dissemination and implementation science frameworks. The research directly addresses the rising incidence of youth-onset type 2 diabetes, which has increased 95% since 2001 and 77% during the COVID-19 pandemic. By integrating real-time assessments of physical activity barriers and facilitators, the JITAI will deliver tailored intervention strategies to support improved diabetes self-management outcomes in this high-risk population. This career development award aligns with NIDDK's programmatic priorities in fundamental and clinical studies on prevention and treatment of diabetes and its complications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $183.5k | 4/27/26 |